FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)

View source ↗

Summary

The FDA approved a supplemental application for Prezista (darunavir) from Janssen Products LP. The action updates the labeling/indication for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREZISTA (darunavir)

Snippet

SUPPL AP for PREZISTA (DARUNAVIR)